Company: BPAC
Filing Date: 2025-06-26
Form Type: S-1
Source: 0001185185-25-000701
Chunk: 9

Company: Blueport Acquisition Ltd
Filing Date: 2025-06-26
Form: S-1
Chunk 9
---

and the sale of the private units described in this prospectus, $69,000,000, or $79,350,000 if the underwriters’ over-allotment
option is exercised in full ($10.00 per unit or 100% of the gross proceeds of the offering in either case), will be deposited into a United
States-based trust account at a United States chartered commercial bank with consolidated assets
of $100 billion or more selected by Wilmington Trust, National Association, (“Wilmington Trust”) acting as trustee.
Such amount includes $0.20 per unit, or $1,380,000 (or $1,587,000 if the underwriters’ over-allotment option is exercised in full)
in the aggregate, payable to the underwriters as deferred underwriting discounts and commissions only upon the completion of our initial
business combination. Except as described in this prospectus, these funds will not be released to us until the earlier of the completion
of our initial business combination and our liquidation upon our failure to consummate a business combination within the required time
period. The majority of our assets may be located outside the United States after we consummate our initial business combination.

In February 2025, an aggregate of 1,983,750 initial shares were issued to our sponsor, for an aggregate purchase price of $25,000, or approximately $0.013 per share. Because our sponsor acquired the initial shares at a nominal price, our public shareholders will incur an immediate and substantial dilution upon the closing of this offering, assuming no value is ascribed to the rights included in the units. Further, the Class A ordinary shares issuable in connection with the conversion of the initial shares may result in material dilution to our public shareholders due to the anti-dilution rights of our initial shares that may result in an issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion. See the section titled “Risk Factors — Risks Relating to our Management Team — The nominal purchase price paid by our sponsor for the initial shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline.”

To illustrate, the table below shows possible sources of dilution and the extent of such dilution that